rizatriptan has been researched along with 3-(2-carboxyindol-3-yl)propionic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdelrahman, A; Akkari, R; Alshaibani, S; Baqi, Y; Ghasimi, S; Kaufmann, O; Köse, M; Kostenis, E; Müller, CE; Namasivayam, V; Pillaiyar, T; Rafehi, M; Ritter, K; Simon, K; Spinrath, A; Zhao, Q | 1 |
1 other study(ies) available for rizatriptan and 3-(2-carboxyindol-3-yl)propionic acid
Article | Year |
---|---|
3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Calcium; Humans; Indoles; Models, Molecular; Molecular Structure; Protein Conformation; Rats; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |